Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		10,518,539
Beginning balance at Dec. 31, 2022	$ 18,111	$ 11	$ 153,872	$ (135,772)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance cost (in shares)		43,161
Issuance of common stock for cash, net of issuance cost	44		44
Stock-based compensation	446		446
Net loss	(7,636)			(7,636)
Ending balance (in shares) at Mar. 31, 2023		10,561,700
Ending balance at Mar. 31, 2023	10,965	$ 11	154,362	(143,408)
Beginning balance (in shares) at Dec. 31, 2022		10,518,539
Beginning balance at Dec. 31, 2022	$ 18,111	$ 11	153,872	(135,772)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	413
Net loss	$ (15,217)
Ending balance (in shares) at Jun. 30, 2023		12,583,833
Ending balance at Jun. 30, 2023	5,012	$ 13	155,988	(150,989)
Beginning balance (in shares) at Mar. 31, 2023		10,561,700
Beginning balance at Mar. 31, 2023	10,965	$ 11	154,362	(143,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance cost (in shares)		537,546
Issuance of common stock for cash, net of issuance cost	1,186	$ 1	1,185
Exercise of pre-funded warrants, shares		1,484,174
Exercise of pre-funded warrants	1	$ 1
Stock-based compensation	440		440
Exercise of stock options (in shares)		413
Exercise of stock options	1		1
Net loss	(7,581)			(7,581)
Ending balance (in shares) at Jun. 30, 2023		12,583,833
Ending balance at Jun. 30, 2023	5,012	$ 13	155,988	(150,989)
Beginning balance (in shares) at Dec. 31, 2023		22,045,255
Beginning balance at Dec. 31, 2023	26,768	$ 22	192,009	(165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with at the market offering (net of issuance costs), shares		56,288
Issuance of common stock in connection with at the market offering (net of issuance costs)	253		253
Issuance of common stock under equity plan awards (in shares)		115,722
Issuance of common stock under equity plan award	197		197
Stock-based compensation	1,318		1,318
Net loss	(7,904)			(7,904)
Ending balance (in shares) at Mar. 31, 2024		22,217,265
Ending balance at Mar. 31, 2024	20,632	$ 22	193,777	(173,167)
Beginning balance (in shares) at Dec. 31, 2023		22,045,255
Beginning balance at Dec. 31, 2023	$ 26,768	$ 22	192,009	(165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	81,699
Net loss	$ (17,474)
Ending balance (in shares) at Jun. 30, 2024		24,475,799
Ending balance at Jun. 30, 2024	16,939	$ 24	199,652	(182,737)
Beginning balance (in shares) at Mar. 31, 2024		22,217,265
Beginning balance at Mar. 31, 2024	20,632	$ 22	193,777	(173,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with at the market offering (net of issuance costs), shares		2,133,534
Issuance of common stock in connection with at the market offering (net of issuance costs)	4,557	$ 2	4,555
Issuance of common stock under equity plan awards (in shares)		125,000
Stock-based compensation	1,320		1,320
Net loss	(9,570)			(9,570)
Ending balance (in shares) at Jun. 30, 2024		24,475,799
Ending balance at Jun. 30, 2024	$ 16,939	$ 24	$ 199,652	$ (182,737)